17. Syntheses and uses of isotopically labelled compounds |
979 |
beams of only 10 15 A cannot be used in the above procedure. The [11C]cyanide can also be prepared250 in high yield in a simple on-line gas-flow system using a low-energy cyclotron by producing [11C]CO2 by irradiation of N2 gas, combining it in line with H2, drying, mixing on line the 11CO2/H2 with NH3 (desiccated over solid KOH) and finally passing the [11C]CO2 H2 NH3 mixture through a quartz tube, containing platinum wire, installed in a furnace held at 950 °C. The [11C]cyanide is extracted from the outflow from the quartz tube in a glass column packed with quartz wool impregnated with NaOH. The trapped radioactivity has been eluted with water. The radioactivity of the starting [11C]CO2 was comparable to the radioactivity of the produced [11C]CN .
1 |
|
|
R1 |
R |
|
|
|
R2 |
1. [11C]CN −, NaHSO3 , H2 O |
R2 |
|
|
55°C, 5 min, extactions with ether |
|
|
|
or 2. [11C]HCN, methanolic acetate buffer (pH 5.4) |
|
|
|
1-2 units of enzymea ,b , RT, 10 min, work up |
|
|
CHO |
|
N11C |
OH |
|
|
(239a) R1 = OH, R2 = H
(238)
(239b) R1 = H. R2 = OH
(a) enzym for 239a: hydroxymandelonitrile lyase |
|
|
|
(b) enzym for 239b: mandelonitrile lyase |
|
(128) |
|
1 M THF, 55 °C, 8 mi n, work-up |
|
||
BH3 |
− THF |
||
|
R1
R2
11
HO CH2 NH2
(237a) R1 = OH, R2 = H
(237b) R1 = H, R2 = OH
(b) Optimization of earlier methods of 240 production from [11C]CO2 for routine synthesis of [1-11C]amino acids has been investigated by lwata and coworkers251. More than 95% radiochemical yields of 240 have been obtained at 5 vol% of NH3. 99% yield of 240 was achieved when metallic sodium coated on quartz wool was used to adsorb traces of O2 which interfere with the catalytic reaction of [11C]CH4 with NH3 on Pt. Higher NH3 concentration prevents the oxidation of [11C]CH4. Higher flow rates and shorter contact time gave higher conversion yield of [11C]CH4 to 240. High yield of 240 was obtained over the temperature interval 850 to 950 °C. Above 950 °C a slight decrease in yield of 240 was observed due to its decomposition. The effect of the Pt amount on the yield of 240 was also studied.
980 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
(c) As regards synthesis of NCA [11C]amino acids from 240, the optimal conditions for the synthesis of NCA[111C]amino acids according to the procedure shown in equation 129 have been chosen251. The best reaction temperature, time and HCl concentration for acid hydrolysis of aminonitriles were found to be 160 °C, 15 min and 6N, respectively. The replacement of the bisulphite group by [11C]cyanide proceeded quantitatively. The following [1-11C]amino acids have been prepared according to the above procedure within about 1 h: phenylglycine, ˛-methylphenylglycine, cyclohexylglycine, phenylalanine, aminocyclohexanecarboxylic acid, aminocyclopentanecarboxylic acid, valine, leucine and norleucine in about 50% radiochemical yield. The method of equation 129 is suitable for automation of [1-11C]amino acid production.
|
|
|
|
|
|
|
OH |
|
NH4 OH |
NH2 |
|
|
|
O + NaHSO3 |
|
|
|
|
|
|
|
||
R1R2 C |
|
|
|
R1R2 C |
|
|
R1R2 C |
|
|||
|
|
|
|
|
|||||||
|
|
||||||||||
|
|
|
|
|
|
|
SO3 Na |
|
|
|
SO3 Na |
|
|
|
|
|
|
|
|
60 °C, 10 min |
|
||
|
|
|
|
|
|
|
|
|
|
11CN − |
(129) |
|
|
|
|
11 COOH |
|
11CN |
|
||||
|
|
R1R2 C |
|
|
|
R1R2 C |
|
||||
|
|
|
|
|
|
||||||
|
|
|
|
NH2 |
|
NH2 |
|
B. Compounds Labelled with Carbon-14
1. Synthesis of [1-14C]-2-2-difluoroethene (241)
1,1-Difluoroethene (DFE) is a volatile industrial monomer widely used in the production of a variety of polymers. DFE-induced hepatotoxicity and acetonemia have been detected in the rats252 254. 241 has been therefore synthesized255 to expedite study of the metabolic fate of the carbon fragment of 241 (equation 130). 241 has been obtained in low yields of 10 15%, caused by trace amounts of water which destroy the intermediates 243 and 242 (equations 131 and 132).
O |
|
|
|
|
O |
O |
|
|||||||||
(EtO)2 PCF2 H |
LDA |
(EtO)2 PCF2 Li |
Me3 SiCl |
(EtO)2 PCF2 SiMe3 |
|
|||||||||||
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|||||||||||
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
(243) |
|
|
|||
|
|
|
|
CsF (cat.), RT |
|
|
|
|
|
|
||||||
|
|
|
|
over night under N2 |
|
|
|
|
|
|
||||||
O |
|
|
|
|
|
|
|
14 CH2 O / THF |
(130) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(EtO)2 PCF2 |
14 CH2 OSiMe3 |
4 h reflux under flow of helium |
14 CH2 |
|||||||||||||
|
|
|
|
|
|
|
F2 C |
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
||||||||||
|
|
CsF |
|
|
|
|
||||||||||
|
(242) |
|
|
|
|
|
(241) |
|||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
O |
|
||||
|
|
|
|
+ |
(EtO)2 |
|
PO−Cs+ + |
Me3 SiF |
||||||||
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
O |
|
|
|
|
|
|
||
|
|
|
243 |
|
H2 O |
|
|
|
|
|
|
|
(131) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
(EtO)2 PCF2 H |
|
|||||||||
|
|
|
|
|
|
|
CsF
17. Syntheses and uses of isotopically labelled compounds |
981 |
||||||
|
|
O |
|
||||
242 |
H2 O |
|
|
|
|
(132) |
|
|
|
||||||
|
(EtO)2 PCF2 14 CH2 OH |
|
|||||
|
|
CsF
2. Synthesis of 3-phenoxy[1-14C]- and 3-phenoxy[3-14C]propene (244 and 245)
244 and 245 have been synthesized258 (equations 133 and 134) for 14C KIE studies in the Claisen rearrangement.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
HOCH2 CH2 Cl |
|
KCN/EtOH/H2 O |
|
|
|
|
|
|
conc. HCl |
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
HOCH2 CH2 CN |
|
|
|
|
|
|
ClCH2 CH2 COOH |
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. conc. HCl |
|
1. PhOH, KOH/H2 O |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
LiA lH4 |
|
|
|
|
|
|
|
Me2 |
NCOCl |
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
PhOCH2 CH2 CH2 NMe2 |
|
|
|
|
|
PhOCH2 CH2 CNMe2 |
|
|
|
|
|
|
PhOCH2 CH2 COOH |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
benzene/Py |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MeI/EtOH |
|
|
|
|
|
|
|
|
|
|
|
|
O |
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
+ |
|
|
|
|
|
1. A gOH/H2 O, RT, 20h |
|
|
|
PhOCH2 CH |
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
− |
|
|
|
|
|
|
|
|
|
|
|
|
CH2 |
|
|
||||||||
PhOCH2 CH2 CH2 NM3 I |
|
|
2. 160°C, |
∆, work-up |
|
|
|
|
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(244) |
|
|
|
|
|
(133) |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
A c2 O |
|
|
|
|
|
|
|
|
|
dry EtOH, p-TSA / CHCl3 |
|
|
|
|
|
|
||||||||||||
CH3 COOH |
|
|
|
|
|
ClCH2 COOH |
|
|
|
|
|
|
|
|
|
|
|
ClCH2 COOEt |
||||||||||||
Cl2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LiA lH4 / A lCl3 / ether |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
KCN |
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
HOCH2 CH2 CN |
|
|
|
|
|
|
|
|
|
|
|
ClCH2 CH2 OH |
|||||||||||||
|
|
|
|
|
|
as i n equation 133 |
|
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
as in equation 133 |
|
|
|
|
|
|
|
|
(134) |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PhOCH2 CH CH2
(245) 2.1% overall yield
= 14 C label
3.Synthesis of [2,3,4,5-14C]-1-vinylpyrrolidinone (246)
NVP, 246, is the intermediate in the production of PVP (polyvinylpyrrolidinone)257 widely employed in the pharmaceutical, medicinal, food and beverage industries, and the small quantities (0.2% or less) of NVP contained as impurity in PVP might present a certain risk for the general population. Studies on the in vivo disposition of NVP have therefore been undertaken and 246 has been synthesized258 (equation 135). [3,4-3H]-NVP and [4-3H]-NVP have been prepared previously in low yields259 because the volatility of NVP itself and of the vinyl acetate had not been controlled properly in the synthetic and
982 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
separation procedures.
H2 N COOH
1. HMDS / MeCN |
|
|
||
|
|
|||
|
|
|||
2. MeOH |
||||
NH |
O |
|||
|
|
|||
|
|
(247) |
||
Na2 PdCl4 / K2 CO3 |
|
|
|
|
|
|
N O
HMDS = hexamethyldisilane |
(246) |
(135)
CH2 CHOOCCH3
4. Synthesis of 14C-labelled catechol-O-methyltransferase inhibitors
The two title COMT enzymes (inhibitors), which may open new possibilities for the treatment of Parkinson’s disease260,261, namely 3-(3,4-dihydroxy-5-nitropenylmethyli- dene)-2,4-pentadione (248) and E-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acryloamide (249), have been labelled262 with carbon-14 using [carbonyl-14C]vanillin as the starting compound (equation 136). [14C-]-248 and- 249 are necessary in studies of the mechanism and pharmacokinetic properties of these drugs.
|
|
|
|
|
|
MeO |
CHO |
|
|
MeO |
CHO |
|
|
|
|
|
|
|
|
|
HNO3 |
/ CH2 Cl2 |
|
|
HO |
|
HO |
|
|
|
NO2 |
|
|
|
|
3.6 mCi |
|
|
|
|
|
|
|
|
|
|
48% HBr |
|
|
|
|
HO |
|
COCH3 |
HO |
CHO |
|
||
|
|
|
2, 4-pentanedione / THF / toluene
COCH3 (136)
HO |
|
HO |
|
|
|
|
|
NO2 |
|
NO2 |
|
|
|
(248) |
|
|
|
|
|
|
|
|
O |
N, N-diethyl-2-cyanoacetamide, piperidine, |
HO |
|
N |
acetic acid, molecular sieves |
|
||
|
|
||
|
|
|
CN |
|
HO |
|
|
NO2
(249)
17. Syntheses and uses of isotopically labelled compounds |
983 |
5. Synthesis of [14C]-labelled eutypine (250)
The 4-hydroxy-3-(3-methyl-3-buten-1-ynyl)benzaldehyde, 250, a phytotoxic compound responsible for vineyard die-back, has been [14C]-labelled263 via Wittig reaction using [14C]CH3I as precursor (equation 137).
CHO |
OH |
|
|
OH |
|
|
|
|
|
|
|
|
|
|
|
7 steps |
O |
|
CH2 |
|
|
|
PPh3 CH2 / THF |
|
OH |
OMOM |
1. CH2 Cl2 |
/ CrO3 − Py2 |
OMOM |
|
|
|
2. hydrolysis |
(137) |
|
|
|
|
CHO
CH2
OMOM = methoxymethyloxy |
OH |
(250) [14 C] Eutypine |
6. Synthesis of [methoxy-14C]eugenol (251)
251 has been synthesized264 in reaction of mesylate 252 with 14CH3I (equation 138). 251 has been needed to evaluate the transfer and fate of eugenol during the smoking of clove cigarettes, to determine its deposition in various organs of rodents exposed to clove cigarette smoke and to investigate the related health effects265.
OH |
OSO2 Me |
OSO2 Me |
OMe |
OMe |
OH |
|
MeSO2 Cl |
BBr3 |
|
CH2 Cl2 |
|
CH2 |
CH2 |
CH2 |
|
|
(252) |
|
|
(138) |
|
|
14 MeI, K2 CO3 |
|
OSO2 Me |
OH |
|
O14 CH3 |
O14 CH3 |
|
NaOH, MeOH |
|
|
CH2 |
CH2 |
(251) 95%yield
984 |
Mieczysław Ziełinski´ and Marianna Kanska´ |
7. Synthesis of 14C-labelled prinomide (253)
Prinomide, 253, a potential aspirin-like NSAID266 (non-steroic anti-inflammatory drug) and its metabolite 254 have been synthesized267 following as in equations 139 141. 253a, 253b and 254 are used in pharmacokinetic and metabolism studies267,268.
1. n-BuLi 2. 14 CO2 |
|
14 COOH |
CH2 N2 |
|
14 COOMe |
|
N |
N |
|
N |
|||
|
|
|
|
|||
Me |
Me |
|
|
|
Me |
|
|
|
|
|
|
NaH, CH3 CN |
|
CN |
|
|
|
|
|
|
14 C |
NHPh |
PhN |
C |
O |
14 C |
|
|
|
|
|
CN |
||
N |
|
|
|
|
N |
|
OH |
O |
|
|
|
O |
|
Me |
|
|
|
|
Me |
|
[14 C] -(253a) |
|
|
|
|
|
(139) |
|
|
|
|
|
|
|
C |
CN + |
O |
C |
N |
|
|
N |
|
|
|
|
|
|
O |
|
|
|
|
|
|
Me |
|
|
|
|
|
|
|
CN |
|
|
|
|
(140) |
|
|
|
|
|
|
|
|
|
NH |
|
|
|
|
N |
C |
|
|
|
|
|
|
|
|
|
|
|
|
Me |
OH |
O |
|
|
|
|
|
|
|
|
|
|
[U-14 C]-(253b)
= uniformly 14 C ring labelled
8.Synthesis of [3-14C]acetocetate (255)
255 and other labelled ˇ-keto esters have been obtained in quantitative yield for the synthesis of many types of pharmaceuticals269 by heating of magnesium ethyl malonate with labelled 1-[14C]acetylimidazole followed by acid hydrolysis and decarboxylation (equation 142).
9. Syntheses of [14C]labelled ketones |
|
Numerous [14C]labelled ketones have been synthesized270 |
by the acylation |
of trimethylsilyl-2-lithiomalonates and trimethylsilyl-2-lithioalkane |
carboxylates with |
17. Syntheses and uses of isotopically labelled compounds |
985 |
[1-14C]acyl halides (equation 143) and applied for the synthesis of different [14C]labelled compounds, mainly biochemicals. A whole variety of labelled acyl halides, prepared from corresponding [14COOH]acids, synthesized directly from 14CO2 or via the [14C]cyanide route, have been utilized in reaction 143. 14C-Labelled biochemicals such as chlorophacinone, amphetamine, olivetol, heptadecane, indole, pyridazine derivatives, 5-aminolevulinic acid, noradrenaline, showdomycine, myosmine, nornicotine, nicotine, cotinine, norcotinine, coniine, palmitic or stearic acid, and other compounds, have been prepared by the method outlined in equation 143 by Pichat270.
|
CNCH2 Cl / ether / HCl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
N |
|
|
|
|
|
|
N |
|
|
Cl |
|
|
|
|
|
|
|
|
|||
Me |
|
|
|
|
|
|
Me |
O |
|
|
|
|
K14 CN / 18-crown / MeCN |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
14 CN |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 CN |
N |
|
|
|
NHC6 H4 OMe-p |
p-MeOC6 H4 N |
|
|
C |
|
O |
(141) |
||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
N |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Me |
O |
O |
|
|
|
|
|
|
|
|
|
|
|
|
|
Me |
O |
||||
|
|
|
|
BBr3 |
14 CN |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
NHC6 H4 OH-p |
|
|||||||||
|
|
|
|
|
|
|
N |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Me |
OH |
O |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O |
[14 C]-(254) |
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R |
|
|
O |
R |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
COOEt |
|
||||||||||
N |
+ |
Mg |
|
|
|
|
|
|
|
|
|
(142) |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
N |
O |
|
|
O |
|
O |
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
= carbon-14 label |
|
|
|
|
|
OEt |
|
(255) |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(143) |
|||||
R1COX + R2CLi(COOTMS) |
2 |
|
|
|
R1COCR2(COOTMS) |
|
|
H+ |
|
|
R1 |
|
|
|
CCH2 R2 |
||||||
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
R2 D H, Me, Et, Pr, Bu, CH2COOTMs, CHMeCOOTMS, NHAc, CH2CN,
CH2CH2CN, (EtO)2CH2CH2 , CH2 mCOOTMS
10. Synthesis of [phenyl-14C]benzazepine derivative SK and F 103829-J
99% pure [6-14C]SK and F 103829-J, 256, has been prepared271 in 10% overall radiochemical yield from 14CH3I and the key substrate, enol lactone, 257 (equation 144).
11. Synthesis of methyl 3-oxo-4,4-dimethylpentanoate-1,3 14C (258)
258 has been synthesized272 as shown in equation 145.
986 Mieczysław Ziełinski´ and Marianna Kanska´
12. Synthesis of [ 14C]-fentanyl (259)
259, a potent opioid analgesic with a faster onset and shorter duration than morphine273,274, has been 14C-labelled275 in the anilidopiperidine substructure, resistant to metabolic extraction of the 14C-label, using [UL-14C]aniline as a source of carbon-14 (equation 146).
|
|
|
|
|
NBn |
MeMgI |
|
|
|
O |
|
|
|
|
O |
O |
O |
|
Me |
|
(257) |
|
|
|
NBn |
|
|
MeO |
|
O |
|
|
|
MeSO2
NH.MsOH
HO
(256)
|
|
|
Mg |
14 CO2 |
2MeLi |
||||||||
Me3 CCl |
|
|
Me3 CMgCl |
|
|
|
|
|
Me3 C14 COOH |
14 CO2 |
|||
|
|
|
|
|
|||||||||
Me3 C14 |
|
CCH2 |
14 COOMe |
CH2N2 |
|
Me3 C14 |
|
CCH2 14 COOH |
|||||
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
O |
|
|
|
|
|
|
O |
|
(258)
13. Synthesis of the cardiotonic agent 14C-loprinone (260)
NBn
NBn
(144)
Me3 C14 COMe
NaNH2
(145)
14 − +
Me3 C CCH2 Na
O
260 presently under development276 for the treatment of congestive heart failure, has been 14C-labelled for pharmacokinetic profile studies277. 260 (14C-loprinone hydrochloride) has been synthesized using 262 (equation 147).
14. Synthesis of [ 14C]-labelled perlrinone (263)
263, a potent inotropic agent (AY-28, 768 hydrochloride), selected for clinical
development278, has been 14C-labelled in four steps (equation 148) for metabolic studies279.
|
17. Syntheses and uses of isotopically labelled compounds |
987 |
||||
O |
|
|
|
|
|
|
|
|
|
|
|
CH2 CH2 Ph |
|
+ |
|
NaBH(A cO)3 |
/ THF |
|
N |
|
|
|
|||||
|
|
|
|
|||
N |
|
|
|
NH |
|
|
CH2 CH2 Ph |
NH2 .HCI |
|
|
|
|
|
|
|
|
EtCOCl, RT |
|
|
|
|
|
|
|
|
(146) |
|
|
|
|
|
|
|
|
|
|
N |
CH2 CH2 Ph |
|
|
|
|
|
|
|
14 |
C] |
|
|
|
|
||||
|
|
|
= [UL - |
N
OEt
(259)18% overall r. yield, r. purity > 99%, sp. act. 2.4 mCi/mmol
N
|
1. Mg, EtBr / THF |
|
|
|
|
N |
2. ClCH2 CMe |
|
|
|
|
Br |
|
CH2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
O3 / dil. HCl-MeOH |
|
|
|
O |
|
|
|
|
|
|
Me2 NCH(OMe)2 |
O |
|
|
|
|
|
||
|
|
|
DMF |
|
|
|
|
N |
|
|
(147) |
|
|
|
|
|
|
|
|
(261) |
|
|
|
MeONa / EtOH |
|
|
|
|
|
|
|
|
|
|
|
|
NCCH2 CONH2 , 262 |
|
|
|
|
|
|
|
N |
|
|
|
CN |
|
N |
|
CN |
|
HCl / EtOH |
||||
|
|
|
|
HCl.H2 O |
|
|
|
|
|
|
|
NH |
O |
|
|
NH |
O |
|
|
|
|
(260)
988 |
|
Mieczysław Ziełinski´ and Marianna Kanska´ |
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1. NaCN |
|
|
|
|
||
|
|
ClCH2 |
COOH |
|
|
NCCH2 COOEt |
|
|
||||
|
|
2. EtOH, |
|
|
||||||||
|
|
|
|
|
|
|
1. CS2 ,KOH / dioxane, 15 − 20 ˚C |
|||||
|
|
|
|
|
|
H2 SO4 |
|
|||||
|
O |
|
|
|
NH |
|
2. (MeO)2 SO2 / EtOH, 0 |
°C |
||||
|
|
|
|
|
|
|
|
|
||||
|
N |
CN |
|
1. CH3 CNH2 .HCl, NaH / DMF, |
|
MeS |
|
|||||
|
|
|
|
2. conc.HCl |
|
|
CN |
|
||||
|
|
|
|
|
|
|
|
|
|
|||
Me |
|
|
|
|
|
|
|
|
|
MeS |
COOEt |
|
NH |
SMe |
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
3-aminomethylpyridine |
|
|
|
|
(148) |
|||
|
Dimethoxyethane, 18 h reflux |
|
O |
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CN |
|
|
|
|
|
|
|
|
|
N |
|
|
|
|
|
||
|
|
|
|
Me |
|
NH |
NH |
|
N |
|
|
|
= position of14 |
C label |
|
(263) |
|
|
|
|
15. Synthesis of [2-14C]-labelled 2,20 -anhydrouridine (264) 20 -deoxyuridine derivatives (265) and 5-ethynyl- and 5-ethyl-20-deoxyuridine (266)
The title compounds 264 266, possessing significant activity against the Herpes simplex viruses280,281, have been synthesized282 according to equation 149. The higher specific activity of 266b than that of 264 is caused probably not by the 14C KIE in the transfor-
|
N |
N |
||
mation of |
C |
bond system in 264 into |
C |
bond system in 267 but by |
|
|
|
||
O |
|
N |
O |
N |
the smaller LSC counting efficiency of not well dried [2-14C]264 sample.
16. Synthesis of 14C-labelled azasteroids
The azasteroids 268 and 269 of potential clinical utility for the treatment of acne, hirsutism or prostatic hypertrophy, have been 14C-labelled in ring A and the t-butyl portion of carboxamide for metabolism and bioavailability studies283.
17. Synthesis of [phenyl-U-14 C]tefluthrin (270)
270, a synthetic insecticide active against soil pests, has been 14C-labelled284 for metabolism and residues studies (equation 150).
18. Disposition of [14C]prinomide (271) in normal subjects
The disposition of this new 14C-labelled anti-inflammatory drug, 271, and its metabolite, 272, in 4 volunteers has been studied285. The elimination half-life of 271 was about